Crossmark

Intra-articular platelet-rich plasma demonstrates superior clinical and serum biomarker outcomes compared with corticosteroids and NSAIDs in late-stage knee osteoarthritis: a randomised controlled trial

Crossref DOI link: https://doi.org/10.1186/s13018-026-07013-w

Published Online: 2026-06-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lacko, Marek

Awad, Omar

Matúška, Martin

Strážik, Michal

Barej, Juraj

Filip, Vladimír

Slovinská, Lucia

Matejová, Jana

Harvanová, Denisa
Funding

Funding for this research was provided by:

Ministerstvo školstva, vedy, výskumu a športu Slovenskej republiky (VEGA no. 1/0686/24)
License Information

Text and Data Mining valid from 2026-06-02

Accepted Manuscript valid from 2026-06-02
More Information

Article History

Received: 4 March 2026

Accepted: 26 May 2026

First Online: 2 June 2026

Declarations

:

: The present study was approved by the ethics committee of the University hospital of Louis Pasteur in Kosice (ID: 2022/EK/10078). All patients signed informed consent to participate to the present study.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below